Contributors


BRADY L . STEIN, M.D., M.H.S.

Latest:

Through Thick and Thin: Monitoring Blood Clots With ET

Patients with essential thrombocythemia should know the signs and symptoms of blood clots.



Yania Jansen

Latest:

When to Stop Immunotherapy Treatment for Melanoma

Yania Jansen, surgical trainee at Vrije Universiteit Brussel, in Brussels, Belgium, discusses the possibility of stopping treatment with Keytruda (pembrolizumab) for patients with melanoma.



Jennifer Wider, MD, Society for Women’s Health Research

Latest:

The Pitfalls and Promises of Diagnosing Ovarian Cancer Early

Ovarian cancer, also known as “the silent killer,” may soon be detected earlier, giving women improved survival rates, with the recognition of specific early warning signs which including abdominal pain, abdominal bloating, urinary urgency or frequency, pelvic and lower back pressure, loss of appetite or feeling full quickly and abnormal vaginal bleeding.


LESLIE R. SCHOVER, PH.D.

Latest:

Finding Your PATHS and Addressing Sexual Health

A free online pilot program helps people with cancer and their partners work through sexual health and fertility obstacles.


Andy Seibert

Latest:

Survivorship's Gift to a Mother and Son

In the midst of all of the things that tie us together, it’s been what many would consider the most challenging shared experience a mother and son can have – facing and surviving cancer – that has been a defining feature of our relationship and ultimately one of the most overwhelming blessings of life.


Jacquelyn Pryor, Ph.D.

Latest:

How One Oncology Nurse Exhibits the Best of Humanity

An Extraordinary Healer essay honoring TARA CHRISTION, B.S.N., RN [BONE MARROW TRANSPLANT GROUP OF GEORGIA, ATLANTA]


Mellisa Wheeler

Latest:

Implementing a Mobile Lung Cancer Screening Unit

Mellisa Wheeler, director of Disparities at the Levine Cancer Institute, discusses how her team came to recognize the need for a mobile lung cancer screening unit.


Jason R. Gotlib

Latest:

Jason R. Gotlib on JAK Inhibitors for the Treatment of Myelofibrosis

Jason R. Gotlib discusses JAK inhibitors for the treatment of patients with myelofibrosis.



Grant Williams, M.D.

Latest:

Using Body Composition to Dose Cancer Treatment

Grant Williams, M.D., clinical instructor and research fellow at UNC Lineberger Cancer Center, discusses the potential of using body composition to better dose cancer treatments such as chemotherapy.


Kalia Douglas-Micallef

Latest:

Restoring My Faith in Medicine — and Humanity

An Extraordinary Healer essay honoring MASSEY NEMATOLLAHI, RN, M.SC.N., OCN, CON(C) [CLINICAL COORDINATOR, ONCOLOGY CLINICAL TRIALS, ADJUNCT CLINICAL APPOINTEE, LAWRENCE S. BLOOMBERG FACULTY OF NURSING — UNIVERSITY OF TORONTO, STRONACH REGIONAL CANCER CENTRE AT SOUTHLAKE, NEWMARKET, ONTARIO, CANADA]


Jasmine Martin

Latest:

Jasmine Martin Discusses Oral Adherence

Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.


Melissa (Missy) Grace

Latest:

With Cancer, It's Either Laugh or Cry

An Extraordinary Healer essay honoring Liana (LI) Minarsky, LPN [ Eastern Connecticut Oncology and Hematology in Norwich, Connecticut ]


Sumul Raval, M.D.

Latest:

Sumul Raval Tells Patients With GBM, "I'm Your Quarterback"

Sumul N. Raval, M.D., founder and director of the Zocchi Brain Tumor Center at Monmouth Medical Center and 2016 GBM hero, tells his patients, "I'm your quarterback."


Gary Stromberg

Latest:

"Hey, Cancer, You In There?"

"If cancer wants to come after me again, it better be ready to fight!"



Lori Jaffe

Latest:

Hope Personified: My Tour Guide on My Path to Being a Cancer Survivor

"Cancer is a journey — many use that expression. Well, I do not like this 'journey,' but I adore my tour guide, Ann Puglisi, RN, OCN, an oncology nurse at Kellogg Cancer Center in Evanston, Illinois,” wrote Lori Jaffee.


Ruben Mesa, M.D.

Latest:

MF Progression to Acute Myeloid Leukemia and Subsequent Treatment

Before closing out their program on myeloproliferative neoplasms, Rami Komrokji, MD, and Ruben Mesa, MD, discuss the potential for progression of MF to acute myeloid leukemia and highlight key treatment strategies.


Pamela Harris

Latest:

www.BreastCancerTrials.org

A new clinical trial site for breast cancer patients.


Vinay Jain, MD

Latest:

Message from the Editor

New statistics are promising, but more is needed.



Dr. Brian Koffman

Latest:

The Best Policy to Eliminate Barriers to Care

Regulation changes could eliminate barriers to potentially lifesaving CAR-T cell immunotherapy for patients covered by Medicare or Medicaid.


Christina Izzo

Latest:

Supportive Care Can Impact Long-Term Outcomes in MDS

CURE interviewed Thomas Prebet to gain insight into the importance of supportive care in myelodysplastic syndrome.



Nirav Niranjan Shah, MD

Latest:

Autologous Stem Cell Transplant Should Remain Standard of Care for Certain DLBCL Patients, Expert Says

Dr. Nirav Niranjan Shah explains the data behind why autologous stem cell transplant should remain the standard of care for patients with relapsed chemo-sensitive DLBCL.


Heather Stringer

Latest:

Uncovering New Ways to Make Cancer Surgery Safer

The use of newer tools and techniques may be reducing the risk of surgical site infections and other complications in patients receiving treatment for gynecologic cancers.


chief operating officer of The Lustgarten Foundation

Latest:

A Promising New Treatment Offers Hope in the Fight Against Pancreatic Cancer

Exciting new treatment options for patients with pancreatic cancer are on the rise, thanks to organizations such as the Lustgarten Foundation.


Kathleen Weis, CEO

Latest:

Exciting Advancements for Rare Blood Diseases

Since these are difficult diseases to treat, research has been quite slow over the last decade or so, but continues to pick up, developing new treatments for patients with these diseases.